See more : Nanalysis Scientific Corp. (NSCIF) Income Statement Analysis – Financial Results
Complete financial analysis of SunLink Health Systems, Inc. (SSY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SunLink Health Systems, Inc., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Par Drugs and Chemicals Limited (PAR.NS) Income Statement Analysis – Financial Results
- Incredible Industries Limited (INCREDIBLE.BO) Income Statement Analysis – Financial Results
- Paychex, Inc. (PAYX) Income Statement Analysis – Financial Results
- Hindustan Foods Limited (HNDFDS.BO) Income Statement Analysis – Financial Results
- Senior plc (SNIRF) Income Statement Analysis – Financial Results
SunLink Health Systems, Inc. (SSY)
About SunLink Health Systems, Inc.
SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates through two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates an 84-bed community hospital, which includes an 18-bed geriatric psychiatry unit; and a 66-bed extended care and rehabilitation center. This segment also provides information technology services; and owns unimproved lands. The Pharmacy segment offers institutional and non-institutional pharmacy services; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services. SunLink Health Systems, Inc. was incorporated in 1959 and is based in Atlanta, Georgia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 32.44M | 47.95M | 41.34M | 40.69M | 47.81M | 45.62M | 52.87M | 53.29M | 63.43M | 91.83M | 105.43M | 108.23M | 146.67M | 181.16M | 197.78M | 199.25M | 158.43M | 143.65M | 135.58M | 128.73M | 112.44M | 99.20M | 87.46M | 41.67M | 32.01M | 50.30M | 93.70M | 111.70M | 95.80M | 91.80M | 90.20M | 97.20M | 99.10M | 105.90M | 89.80M | 84.70M | 143.70M | 119.50M | 90.80M |
| Cost of Revenue | 19.54M | 24.05M | 21.24M | 19.07M | 23.16M | 22.69M | 23.02M | 24.53M | 26.98M | 33.70M | 37.90M | 38.94M | 45.32M | 125.01M | 137.05M | 136.87M | 103.00M | 95.04M | 90.00M | 84.00M | 73.93M | 33.04M | 19.16M | 25.94M | 28.51M | 45.80M | 84.50M | 95.70M | 82.50M | 78.20M | 77.30M | 83.60M | 85.80M | 90.10M | 78.10M | 71.80M | 121.10M | 103.30M | 75.60M |
| Gross Profit | 12.90M | 23.90M | 20.11M | 21.61M | 24.65M | 22.93M | 29.85M | 28.76M | 36.46M | 58.13M | 67.53M | 69.29M | 101.35M | 56.15M | 60.73M | 62.38M | 55.43M | 48.61M | 45.58M | 44.73M | 38.51M | 66.17M | 68.29M | 15.74M | 3.50M | 4.50M | 9.20M | 16.00M | 13.30M | 13.60M | 12.90M | 13.60M | 13.30M | 15.80M | 11.70M | 12.90M | 22.60M | 16.20M | 15.20M |
| Gross Profit Ratio | 39.78% | 49.84% | 48.63% | 53.12% | 51.56% | 50.26% | 56.45% | 53.97% | 57.47% | 63.30% | 64.05% | 64.02% | 69.10% | 30.99% | 30.71% | 31.31% | 34.99% | 33.84% | 33.62% | 34.75% | 34.25% | 66.70% | 78.09% | 37.76% | 10.92% | 8.95% | 9.82% | 14.32% | 13.88% | 14.81% | 14.30% | 13.99% | 13.42% | 14.92% | 13.03% | 15.23% | 15.73% | 13.56% | 16.74% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 10.93M | 19.69M | 19.56M | 14.35M | 20.16M | 19.80M | 24.18M | 23.94M | 31.57M | 44.46M | 52.87M | 54.58M | 66.04M | 3.17M | 3.32M | 27.76M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 64.29M | 0.00 | 3.95M | 8.50M | 8.80M | 9.40M | 9.20M | 8.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 10.93M | 19.69M | 19.56M | 14.35M | 20.16M | 19.80M | 24.18M | 23.94M | 31.57M | 44.46M | 52.87M | 54.58M | 66.04M | 3.17M | 3.32M | 27.76M | 44.52M | 39.80M | 34.55M | 35.05M | 32.11M | 59.61M | 64.29M | 15.89M | 3.95M | 8.50M | 8.80M | 9.40M | 9.20M | 8.80M | 8.30M | 8.80M | 9.30M | 8.90M | 7.90M | 9.50M | 18.10M | 18.60M | 10.80M |
| Other Expenses | 4.39M | 510.00K | 5.89M | 5.39M | 4.82M | 5.31M | 944.00K | 7.90M | 10.55M | 12.14M | 14.70M | 15.02M | 37.61M | 48.36M | 54.50M | 28.51M | 5.51M | 4.40M | 3.40M | 2.59M | 2.09M | 2.70M | 1.35M | 849.00K | 813.00K | 1.60M | 1.40M | 1.20M | 1.20M | 1.00M | 900.00K | 900.00K | 900.00K | 900.00K | 800.00K | 1.60M | 1.50M | 600.00K | 600.00K |
| Operating Expenses | 15.32M | 26.22M | 25.45M | 19.74M | 24.98M | 25.11M | 31.84M | 31.84M | 42.12M | 56.60M | 67.57M | 69.59M | 103.65M | 51.53M | 57.81M | 56.27M | 50.03M | 44.20M | 37.95M | 37.64M | 34.20M | 62.31M | 65.65M | 16.74M | 4.76M | 10.10M | 10.20M | 10.60M | 10.40M | 9.80M | 9.20M | 9.70M | 10.20M | 9.80M | 8.70M | 11.10M | 19.60M | 19.20M | 11.40M |
| Cost & Expenses | 34.85M | 50.27M | 46.68M | 38.81M | 48.14M | 47.80M | 54.87M | 56.37M | 69.10M | 90.30M | 105.47M | 108.53M | 148.97M | 176.55M | 194.86M | 193.14M | 153.03M | 139.23M | 127.95M | 121.64M | 108.12M | 95.35M | 84.81M | 42.68M | 33.28M | 55.90M | 94.70M | 106.30M | 92.90M | 88.00M | 86.50M | 93.30M | 96.00M | 99.90M | 86.80M | 82.90M | 140.70M | 122.50M | 87.00M |
| Interest Income | 0.00 | 120.00K | 15.00K | 28.00K | 29.00K | 241.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00K | 14.00K | 5.00K | 14.00K | 50.00K | 72.00K | 69.00K | 75.00K | 42.00K | 0.00 | 56.00K | 56.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 15.00K | 28.00K | 29.00K | 241.00K | 359.00K | 635.00K | 843.00K | 861.00K | 1.22M | 1.80M | 4.39M | 7.43M | 3.47M | 3.77M | 2.97M | 1.57M | 1.34M | 1.68M | 0.00 | 5.02M | 1.36M | 0.00 | 0.00 | 2.20M | 0.00 | 2.30M | 900.00K | 400.00K | 0.00 | 0.00 | 700.00K | 1.00M | 2.20M | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.96M | 1.77M | 1.54M | 1.36M | 1.45M | 1.49M | 1.53M | 1.99M | 1.88M | 2.68M | 3.66M | 4.05M | 4.68M | 6.23M | 6.80M | 6.90M | 5.51M | 4.40M | 3.40M | 2.59M | 2.09M | 1.56M | 1.35M | 849.00K | 813.00K | 1.60M | 1.40M | 1.20M | 1.20M | 1.00M | 900.00K | 900.00K | 900.00K | 900.00K | 800.00K | 1.60M | 1.50M | 600.00K | 600.00K |
| EBITDA | -453.00K | -1.66M | -3.80M | 3.23M | 1.12M | -351.00K | 1.32M | 151.00K | -4.64M | 4.22M | 3.62M | 2.19M | 6.50M | -10.89M | 8.54M | 12.81M | 10.92M | 8.81M | 11.03M | 9.68M | 6.40M | 7.38M | 2.01M | -156.00K | -452.00K | -3.20M | -600.00K | 3.20M | 4.10M | 4.80M | 4.60M | 4.80M | 4.00M | 6.90M | 3.80M | 3.40M | 4.50M | -2.40M | 4.40M |
| EBITDA Ratio | -1.40% | -1.22% | -16.49% | 7.26% | 2.46% | -0.95% | 1.53% | -2.06% | -5.09% | 4.59% | 3.44% | 3.46% | 1.63% | 5.99% | 4.92% | 6.55% | 7.06% | 6.14% | 8.13% | 7.82% | 7.39% | 7.44% | 4.19% | -0.37% | -1.48% | -5.77% | -1.92% | 6.27% | 4.18% | 4.68% | 3.55% | 3.60% | 3.83% | 6.14% | 0.22% | 0.71% | 1.95% | -4.10% | 3.96% |
| Operating Income | -2.41M | -2.32M | -5.34M | 1.87M | -275.00K | -2.19M | -1.99M | -4.51M | -6.52M | 2.53M | -40.00K | -1.10M | 5.91M | -8.73M | 1.72M | 5.68M | 5.41M | 4.41M | 7.63M | 7.09M | 4.32M | 3.44M | 2.65M | -1.01M | -1.27M | -5.60M | -1.00M | 5.40M | 2.90M | 3.80M | 3.70M | 3.90M | 3.10M | 6.00M | 3.00M | 1.80M | 3.00M | -3.00M | 3.80M |
| Operating Income Ratio | -7.43% | -4.84% | -12.92% | 4.60% | -0.58% | -4.79% | -3.77% | -8.46% | -10.28% | 2.76% | -0.04% | -1.01% | 4.03% | -4.82% | 0.87% | 2.85% | 3.41% | 3.07% | 5.63% | 5.51% | 3.84% | 3.47% | 3.03% | -2.41% | -3.95% | -11.13% | -1.07% | 4.83% | 3.03% | 4.14% | 4.10% | 4.01% | 3.13% | 5.67% | 3.34% | 2.13% | 2.09% | -2.51% | 4.19% |
| Total Other Income/Expenses | 95.00K | 1.85M | 3.73M | 5.13M | 39.00K | 107.00K | 541.00K | 2.04M | -833.00K | -840.00K | -1.26M | -1.82M | -646.00K | -15.29M | -3.46M | -3.54M | -2.31M | -1.39M | -1.07M | -1.45M | -6.26M | -45.22M | -948.00K | -311.00K | 142.00K | -200.00K | 1.70M | 1.60M | -1.00M | -900.00K | 200.00K | 0.00 | -1.00M | -1.40M | 1.90M | 1.60M | -500.00K | 2.50M | -600.00K |
| Income Before Tax | -2.32M | -1.66M | -1.62M | 7.00M | -290.00K | -2.08M | -1.48M | -2.47M | -7.36M | 1.69M | -1.30M | -2.89M | 1.51M | -16.16M | -1.74M | 2.14M | 3.10M | 3.02M | 6.56M | 5.64M | -1.94M | 523.00K | 28.00K | -1.32M | -1.12M | -7.10M | 100.00K | 4.00M | 1.90M | 2.90M | 3.90M | 3.90M | 2.10M | 4.60M | 4.90M | 3.40M | 2.50M | -500.00K | 3.20M |
| Income Before Tax Ratio | -7.14% | -3.47% | -3.91% | 17.21% | -0.61% | -4.56% | -2.80% | -4.64% | -11.60% | 1.84% | -1.24% | -2.67% | 1.03% | -8.92% | -0.88% | 1.08% | 1.95% | 2.10% | 4.84% | 4.38% | -1.73% | 0.53% | 0.03% | -3.16% | -3.51% | -14.12% | 0.11% | 3.58% | 1.98% | 3.16% | 4.32% | 4.01% | 2.12% | 4.34% | 5.46% | 4.01% | 1.74% | -0.42% | 3.52% |
| Income Tax Expense | -5.00K | -7.00K | 107.00K | 63.00K | 296.00K | -82.00K | -345.00K | -512.00K | 4.56M | 1.02M | 88.00K | -1.31M | 858.00K | -5.61M | -807.00K | 1.08M | 1.09M | 1.44M | 2.38M | 1.26M | -675.00K | 247.00K | 126.00K | 50.00K | -252.00K | 1.90M | 800.00K | 1.40M | 700.00K | 900.00K | 1.00M | 1.30M | 700.00K | 2.40M | 2.10M | 400.00K | 2.00M | -3.50M | 1.20M |
| Net Income | -1.53M | -1.80M | -1.72M | 6.89M | -586.00K | -2.00M | -1.59M | 2.69M | -14.08M | 245.00K | -545.00K | 4.49M | 1.08M | -10.72M | 102.00K | 912.00K | 1.62M | 1.40M | 3.91M | 4.54M | 13.43M | 553.00K | 833.00K | 478.00K | 1.58M | -8.60M | 300.00K | 2.10M | 1.20M | 2.00M | 1.40M | 2.60M | 1.50M | 2.20M | -4.90M | 1.10M | 500.00K | -2.00M | 2.00M |
| Net Income Ratio | -4.71% | -3.74% | -4.17% | 16.93% | -1.23% | -4.38% | -3.01% | 5.04% | -22.20% | 0.27% | -0.52% | 4.15% | 0.74% | -5.91% | 0.05% | 0.46% | 1.02% | 0.97% | 2.88% | 3.53% | 11.94% | 0.56% | 0.95% | 1.15% | 4.95% | -17.10% | 0.32% | 1.88% | 1.25% | 2.18% | 1.55% | 2.67% | 1.51% | 2.08% | -5.46% | 1.30% | 0.35% | -1.67% | 2.20% |
| EPS | -0.33 | -0.26 | -0.25 | 1.00 | -0.08 | -0.28 | -0.19 | 0.29 | -1.49 | 0.03 | -0.06 | 0.48 | 0.12 | -1.32 | 0.01 | 0.11 | 0.21 | 0.19 | 0.54 | 0.63 | 2.15 | 0.11 | 0.17 | 0.10 | 0.32 | -1.69 | 0.05 | 0.41 | 0.23 | 0.40 | 0.32 | 0.57 | 0.33 | 0.48 | -1.07 | 0.23 | 0.10 | -0.43 | 0.45 |
| EPS Diluted | -0.33 | -0.26 | -0.25 | 0.99 | -0.08 | -0.28 | -0.19 | 0.29 | -1.49 | 0.03 | -0.06 | 0.48 | 0.12 | -1.32 | 0.01 | 0.11 | 0.21 | 0.18 | 0.50 | 0.59 | 2.15 | 0.10 | 0.17 | 0.10 | 0.32 | -1.69 | 0.05 | 0.40 | 0.23 | 0.40 | 0.32 | 0.57 | 0.33 | 0.48 | -1.07 | 0.23 | 0.10 | -0.43 | 0.45 |
| Weighted Avg Shares Out | 7.04M | 7.02M | 6.95M | 6.91M | 6.96M | 7.15M | 8.28M | 9.33M | 9.44M | 9.44M | 9.44M | 9.34M | 9.35M | 8.09M | 8.05M | 7.98M | 7.61M | 7.40M | 7.26M | 7.17M | 6.25M | 5.00M | 4.90M | 4.78M | 4.95M | 5.09M | 6.00M | 5.12M | 5.07M | 5.05M | 4.38M | 4.56M | 4.55M | 4.58M | 4.58M | 4.78M | 5.00M | 4.65M | 4.44M |
| Weighted Avg Shares Out (Dil) | 7.04M | 7.02M | 6.95M | 6.99M | 6.96M | 7.15M | 8.28M | 9.35M | 9.44M | 9.50M | 9.46M | 9.45M | 9.35M | 8.09M | 8.05M | 8.02M | 7.86M | 7.81M | 7.86M | 7.71M | 6.25M | 5.29M | 4.90M | 4.78M | 4.95M | 5.09M | 6.00M | 5.25M | 5.26M | 5.14M | 4.38M | 4.56M | 4.55M | 4.58M | 4.58M | 4.78M | 5.00M | 4.65M | 4.44M |
SunLink Health Systems, Inc. Announces Sale of Trace Regional Hospital Real Estate
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE AMERICAN: SSY) today announced that its subsidiary, Southern Health Corporation of Houston, Inc., and an affiliate, have completed the sale of the hospital building and related real estate of its formerly operated Trace Regional...
SunLink Health Systems, Inc. Announces Fiscal 2024 Fourth Quarter and Annual Results
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $652,000 (or a loss of $0.09 per fully diluted share) for its fourth fiscal quarter ended June 30, 2024 compared to a loss from...
SunLink Health Systems, Inc. Announces Sale of Trace Extended Care & Rehab
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE:AMERICAN: SSY) today announced that its subsidiary, Southern Health Corporation of Houston, Inc., has completed the sale of its Trace Extended Care & Rehab senior care facility and related real estate in Houston, Mississippi for...
SunLink Health Systems, Inc. Announces Fiscal 2024 Third Quarter Results
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $824,000 (or a loss of $0.12 per fully diluted share) for its third fiscal quarter ended March 31, 2024 compared to a loss from...
SunLink Health Systems, Inc. Announces Fiscal 2024 Second Quarter Results
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $407,000 (or a loss of $0.06 per fully diluted share) for its second fiscal quarter ended December 31, 2023 compared to earnings from continuing...
Sunlink Health Systems' Subsidiary Reaches Revised Agreements for the Sale of Trace Regional Medical Center and Clinics
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE: American: SSY) today announced that its indirect subsidiary, Southern Health Corporation of Houston, Inc. (“Southern”), has reached a revised agreement for the sale of Trace Regional Hospital and three (3) patient clinics in Chickasaw...
SunLink Health Systems, Inc. and Progressive Health Group, LLC, Agree to Extend the Closing Date of Their Previously-Announced Sale of Trace Regional Medical Center
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (“SunLink”) (NYSE American: SSY) today announced that SunLink and Progressive Health Group, LLC (“Progressive”) have amended their previously-announced agreement for the sale by SunLink's subsidiary, Crown Healthcare Investments, LLC, of Trace Regional Medical Center in...
SunLink Health Systems, Inc. Announces Fiscal 2024 First Quarter Results
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $428,000 (or a loss of $0.06 per fully diluted share) for its first fiscal quarter ended September 30, 2023 compared to a loss from...
SunLink Health Systems Reaches Agreement for Sale of Trace Regional Medical Center
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE: American: SSY) today announced that its subsidiary, Crown Healthcare Investments, LLC, has signed an agreement with Progressive Health Group, LLC (“Buyer”) for the sale of the subsidiary that owns and operates Trace Regional Medical...
SunLink Health Systems, Inc. Announces Fiscal 2023 Fourth Quarter and Annual Results
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $1,436,000 (or a loss of $0.20 per fully diluted share) for its fourth fiscal quarter ended June 30, 2023 compared to a loss from...
Source: https://incomestatements.info
Category: Stock Reports